Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Liangyan Hospital Management is a China-based healthcare services company focused on medical aesthetics rather than drug development. The company operates or manages aesthetic medical institutions offering surgical aesthetic services, non-surgical aesthetic services, and related clinic operations. It appears to have originated as Jiangsu Momoda Business Information Consulting and later rebranded to Jiangsu Liangyan Hospital Management. The company was acquired by Aesthetic Medical International Holdings Group and functions as an operating subsidiary within that group. Available public information indicates a commercial-stage aesthetic healthcare services business, with no clearly disclosed therapeutic drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Liangyan Hospital Management.